'Protein microarrays' may reveal new weapons against malaria

Dr. Alyssa Barry from the infection and immunity division is using "protein microarray" technology to screen human blood serum samples for immunity to malaria. Credit: The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.

A new research technology is revealing how humans develop immunity to malaria, and could assist programs aimed at eradicating this parasitic disease.

Dr Alyssa Barry from the Walter and Eliza Hall Institute's Infection and Immunity division is using 'protein microarray' technology to screen human samples for immunity to proteins produced by the malaria-causing Plasmodium falciparum parasite. Her research, which determines a person's immunity to hundreds of proteins simultaneously, has been published in the journal Molecular and Cellular Proteomics this month.

Malaria is a mosquito-borne disease that affects more than 500 million people each year. It causes more than one million deaths, mostly in children under five years of age.

Dr Barry is investigating how humans living in countries where malaria is prevalent, such as Papua New Guinea, establish immunity that protects them from developing malaria.

The has evolved many ways to evade the immune system, Dr Barry said. "We know that one , called PfEMP1, that is particularly important for the host can be produced in many different varieties, and these can be altered by the parasite to avoid detection by the immune system."

Dr Barry and colleagues at the Queensland Institute of Medical Research, the Papua New Guinea Institute of Medical Research and the University of California Irvine adapted existing protein microarray technology to allow small samples of human serum (less than one hundredth of a millilitre) to be tested simultaneously against hundreds of variants of PfEMP1 to determine to which variants the person was immune.

Dr Barry said the testing revealed that in a small region of Papua New Guinea where malaria is endemic, children under the age of two are immune to only a few specific variants of PfEMP1 while older children and adults show immunity to an increasing range of PfEMP1 variants.

"Young children are the most vulnerable to malaria," she said. "Our studies show that this is partly because they have not developed immunity to the many different malaria variants to which they are exposed. As people get older, they become immune to a wider spectrum of malaria parasites, and so when they are infected they develop milder disease and eventually do not develop disease at all, although they can still be infected."

The research team is now undertaking a larger study that will screen more people from other regions of , and will screen a wider variety of Plasmodium protein variants.

Dr Barry said she hoped the research would lead to the development of a diagnostic test for susceptibility to malaria, and also determine which proteins might be the best to use as the basis for a malaria vaccine. "We currently do not know how people become to malaria," she said. "Our protein microarray technology could assist in monitoring control and elimination programs, by showing when a population becomes more susceptible to the disease as a result of waning immunity."

Provided by Walter and Eliza Hall Institute

not rated yet

Related Stories

How adhesive protein causes malaria

Sep 25, 2007

Researchers at the Swedish medical university Karolinska Institutet (KI) and the Swedish Institute for Infectious Disease Control (SMI) have identified the biochemical mechanism behind the adhesive protein that give rise ...

Research exposes new target for malaria drugs

Aug 04, 2008

The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune ...

Recommended for you

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

hush1
not rated yet Nov 01, 2011
During which you can encourage the genetic mutation for asymmetrical wing span of all mosquitoes resulting in circular flight. The carry over to other species is without consequence.
No eradication. No extinction. No natural selection pressure.
All species have predictable flight and location.

Buys time and saves lives until you finish your work.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.